Microtech, a wholly owned subsidiary of Medinol, is happy to announce the first U.S. implantations of its atrial-pressure microsensor. Two surgical implantations were performed on Friday, May 16, 2025, at New York-Presbyterian/Columbia University Irving Medical Center by Dr. Koji Takeda, Surgical Director for Adult Heart Transplant at New York-Presbyterian/Columbia.
The Microtech atrial-pressure microsensor is a new class of device, characterized by an extremely small size, entirely passive nature, the absence of any electronics or antenna and its ability to receive and transmit signals via ultrasound. Due to these properties, the Microtech sensors can be used not only as a stand-alone device but can also be integrated onto existing implants, turning them into combination therapeutic-diagnostic smart devices, capable of gathering data and performing multiple functions at once.
The two sensors, implanted in patients who received LVADs at New York-Presbyterian/Columbia, join the 5 microsensors already implanted in Israel under similar conditions. „Implantation of the microsensor was easy and took about 5 minutes, requiring a minimal modification to the LVAD implantation procedure,“ Dr. Takeda said.
